HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner

Journal of Leukocyte Biology

Volumn 76, Issue 1, 2004, Pages 65-76

  Smith, M Shane ^a   Bentz, Gretchen L ^a   Smith, Patrick M ^a   Bivins, Elizabeth R ^a   Yurochko, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus; Endothelial cells; Inflammation; Lifecycle

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; MEDIATOR RELEASE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; MACROPHAGE ACTIVATION; MONOCYTES; UP-REGULATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 3042818883     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203621     Document Type: Conference Paper

References (73)

1. Zhang, L. J., Hanff, P., Rutherford, C., Churchill, W. H., Crumpacker, C. S. (1995) Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J. Infect. Dis, 171, 1002-1006.
2. Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison III, C. A., Kouzarides, T., Martignetti, J. A. (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169.
3. Huang, E. S., Kowalik, T. F. (1993) The pathogenicity of human cytomegalovirus: an overview. In Molecular Aspects of Human Cytomegalovirus Diseases (Y. Becker, G. Darai, E. S. Huang, eds.), Berlin, Springer-Verlag, 1-45.
4. Masur, H., Whitcup, S. M., Cartwright, C., Polis, M., Nussenblatt, R. (1996) Advances in the management of AIDS-related cytomegalovirus retinitis. Ann. Intern. Med. 125, 126-136.
5. Collier, A. C., Meyers, J. D., Corey, L., Murphy, V. L., Roberts, P. L., Handsfield, H. H. (1987) Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am. J. Med. 82, 593-601.
6. Ho, M. (1977) Virus infections after transplantation in man. Brief review. Arch. Virol. 55, 1-24.
7. Stagno, S., Pass, R. F., Cloud, G., Britt, W. J., Henderson, R. E., Walton, P. D., Veren, D. A., Page, F., Alford, C. A. (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256, 1904-1908.
8. Epstein, S. E., Zhou, Y. F., Zhu, J. (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100, e20-e28.
9. Grattan, M. T., Moreno-Cabral, C. E., Stames, V. A., Oyer, P. E., Stinson, E. B., Shumway, N. E. (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261, 3561-3566.
10. Sorlie, P. D., Adam, E., Melnick, S. L., Folsom, A., Skelton, T., Chambless, L. E., Barnes, R., Melnick, J. L. (1994) Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J. Med. Virol. 42, 33-37.
11. Nieto, F. J., Adam, E., Sorlie, P., Farzadegan, H., Melnick, J. L., Comstock, G. W., Szklo, M. (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94, 922-927.
12. Streblow, D. N., Orloff, S. L., Nelson, J. A. (2001) Do pathogens accelerate atherosclerosis? J. Nutr. 131, 2798S-2804S.
13. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T., Epstein, S. E. (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394.
14. Yurochko, A. D., Huang, E. S. (1999) Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162, 4806-4816.
15. Sinzger, C., Jahn, G. (1996) Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39, 302-319.
16. Sinzger, C., Plachter, B., Grefte, A., The, T. H., Jahn, G. (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173, 240-245.
17. Gnann Jr., J. W., Ahlmen, J., Svalander, C., Olding, L., Oldstone, M. B., Nelson, J. A. (1988) Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pathol. 132, 239-248.
18. Manez, R., Kusne, S., Rinaldo, C., Aguado, J. M., St George, K., Grossi, P., Frye, B., Fung, J. J., Ehrlich, G. D. (1996) Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J. Infect. Dis. 173, 1072-1076.
19. Bissinger, A. L., Sinzger, C., Kaiserling, E., Jahn, G. (2002) Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J. Med. Virol. 67, 200-206.
20. Taylor-Wiedeman, J., Sissons, J. G., Borysiewiez, L. K., Sinclair, J. H. (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
21. Sinclair, J., Sissons, P. (1996) Latent and persistent infections of monocytes and macrophages. Intervirology 39, 293-301.
22. Booss, J., Dann, P. R., Griffith, B. P., Kim, J. H. (1989) Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am. J. Pathol. 134, 71-78.
23. Kondo, K., Kaneshima, H., Mocarski, E. S. (1994) Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883.
24. Maciejewski, J. P., Bruening, E. E., Donahue, R. E., Mocarski, E. S., Young, N. S., St Jeor, S. C. (1992) Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80, 170-178.
25. Mendelson, M., Monard, S., Sissons, P., Sinclair, J. (1996) Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77, 3099-3102,
26. Soderberg-Naucler, C., Fish, K. N., Nelson, J. A. (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126.
27. Sindre, H., Tjoonnfjord, G. E., Rollag, H., Ranneberg-Nilsen, T., Veiby, O. P., Beck, S., Degre, M., Hestdal, K. (1996) Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88, 4526-4533.
28. Smith, M. S., Bentz, G. L., Alexander, J. S., Yurochko, A. D. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol., 78, 4444-4453.
29. Collins, T. M., Quirk, M. R., Jordan, M. C. (1994) Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol. 68, 6305-6311.
30. Saederup, N., Lin, Y. C., Dairaghi, D. J., Schall, T. J., Mocarski, E. S. (1999) Cytomegalovirus-encoded β chemokine promotes monocyte-associated viremia in the host. Proc. Natl. Acad. Sci. USA 96, 10881-10886.
31. Stoddart, C. A., Cardin, R. D., Boname, J. M., Manning, W. C., Abenes, G. B., Mocarski, E. S. (1994) Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68, 6243-6253.
32. van der Strate, B. W., Hillebrands, J. L., Lycklama a Nijeholt, S. S., Beljaars, L., Bruggeman, C. A., Van Luyn, M. J., Rozing, J., The, T. H., Meijer, D. K., Molema, G., Harmsen, M. C. (2003) Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo. J. Virol. 77, 11274-11278.
33. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126.
34. Watanabe, T., Haraoka, S., Shimokama, T. (1996) Inflammatory and immunological nature of atherosclerosis. Int. J. Cardiol. 54 (Suppl.), S51-S60.
35. Gerrity, R. G. (1981) The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103, 181-190.
36. Joris, L., Zand, T., Nunnari, J. J., Krolikowski, F. J., Majno, G. (1983) Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am. J. Pathol. 113, 341-358.
37. Faggiotto, A., Ross, R., Harker, L. (1984) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4, 323-340.
38. Li, H., Cybulsky, M. I., Gimbrone Jr., M. A., Libby, P. (1993) An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13, 197-204.
39. Rothlein, R., Dustin, M. L., Marlin, S. D., Springer, T. A. (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137, 1270-1274.
40. Pober, J. S. (1988) Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am. J. Pathol. 133, 426-433.
41. Fan, J., Shimokama, T., Haraoka, S., Tokunaga, O., Watanabe, T. (1993) Monocyte-endothelial cell interactions in vitro, with reference to the influence of interleukin-1 and tumor necrosis factor. Biol. Cell. 79, 17-26.
42. Libby, P., Friedman, G. B., Salomon, R. N. (1989) Cytokines as modulators of cell proliferation in fibrotic diseases. Am. Rev. Respir. Dis. 140, 1114-1117.
43. Raines, E. W., Dower, S. K., Ross, R. (1989) Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243, 393-396.
44. Old, L. J. (1985) Tumor necrosis factor (TNF). Science 230, 630-632.
45. Plutzky, J. (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 88, 10K-15K.
46. Dollery, C. M., McEwan, J. R., Henney, A. M. (1995) Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77, 863-868.
47. Lijnen, H. R., Collen, D. (1999) Matrix metalloproteinase system deficiencies and matrix degradation. Thromb. Haemost. 82, 837-845.
48. Yurochko, A. D., Kowalik, T. F., Huong, S. M., Huang, E. S. (1995) Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69, 5391-5400.
49. Yurochko, A. D., Hwang, E. S., Rasmussen, L., Keay, S., Pereira, L., Huang, E. S. (1997) The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71, 5051-5059.
50. Yurochko, A. D., Liu, D. Y., Eierman, D., Haskill, S. (1992) Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc. Natl. Acad. Sci. USA 89, 9034-9038.
51. Scott, W. N., McCool, K., Nelson, J. (2000) Improved method for the production of gold colloid monolayers for use in the phagokinetic track assay for cell motility. Anal. Biochem. 287, 343-344.
52. (1999) Fundamental Immunology (W. E. Paul, ed.), Philadelphia, PA, Lippincott-Raven.
53. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., Cohen, P. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261-269.
54. Weber, K. S., Klickstein, L. B., Weber, P. C., Weber, C. (1998) Chemokine-induced monocyte transmigration requires cdc42-mediated cytoskeletal changes. Eur. J. Immunol. 28, 2245-2251.
55. Ridley, A. J. (2001) Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett. 498, 168-171.
56. Ronald, J. A., Ionescu, C. V., Rogers, K. A., Sandig, M. (2001) Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4. J. Leukoc. Biol. 70, 601-609.
57. Marchesi, V. T., Florey, H. W. (1960) Electron micrographic observations on the emigration of leucocytes. Q. J. Exp. Physiol. Cogn. Med. Sci. 45, 343-347.
58. Muller, W. A. (2001) Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation 8, 181-193.
59. Osterud, B., Bjorklid, E. (2003) Role of monocytes in atherogenesis. Physiol. Rev. 83, 1069-1112.
60. Holm, T., Damas, J. K., Holven, K., Nordoy, I., Brosstad, F. R., Ueland, T., Wahre, T., Kjekshus, J., Froland, S. S., Eiken, H. G., Solum, N. O., Gullestad, L., Nenseter, M., Aukrust, P. (2003) CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets, and peripheral blood mononuclear cells. J. Thromb. Haemost. 1, 257-262.
61. Reape, T. J., Rayner, K., Manning, C. D., Gee, A. N., Barnette, M. S., Burnand, K. G., Groot, P. H. E. (1999) Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am. J. Pathol. 154, 365-374.
62. Wang, X., Li, X., Yue, T. L., Ohlstein, E. H. (2000) Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. Biochim. Biophys. Acta 1500, 41-48.
63. Krishnaswamy, G., Kelley, J., Yerra, L., Smith, J. K., Chi, D. S. (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 19, 91-104.
64. Reape, T. J., Groot, P. H. (1999) Chemokines and atherosclerosis. Atherosclerosis 147, 213-225.
65. de Waard, V., van den Berg, B. M., Veken, J., Schultz-Heienbrok, R., Pannekoek, H., van Zonneveld, A. J. (1999) Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus. Gene 226, 1-8.
66. Damas, J. K., Gullestad, L., Ueland, T., Solum, N. O., Simonsen, S., Froland, S. S., Aukrust, P. (2000) CXC-chemokines, a new group of cytokines in congestive heart failure-possible role of platelets and monocytes. Cardiovasc. Res. 45, 428-436.
67. Toorkey, C. B., Carrigan, D. R. (1989) Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J. Infect. Dis. 160, 741-751.
68. Fish, K. N., Depto, A. S., Moses, A. V., Britt, W., Nelson, J. A. (1995) Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J. Virol. 69, 3737-3743.
69. Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C., Nelson, J. A. (1991) Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65, 6581-6588.
70. Lathey, J. L., Spector, S. A. (1991) Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65, 6371-6375.
71. Soderberg-Naucler, C., Fish, K. N., Nelson, J. A. (1997) Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100, 3154-3163.
72. Myerson, D., Hackman, R. C., Nelson, J. A., Ward, D. C., McDougall, J. K. (1984) Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15, 430-439.
73. Johnson, R. A., Wang, X., Ma, X. L., Huong, S. M., Huang, E. S. (2001) Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75, 6022-6032.